The sensitivity analysis across a wide IL-6 baseline range (10–1000 pg/mL) observed in RA patients demonstrated a nonlinear relationship between the IL-6 baseline level and simvastatin exposure changes one week after a single IV administration of 10 mg/kg tocilizumab (Figure S1). Here, IL6 is linked to rheumatoid arthritis.